HEART-FID trial: Intravenous ferric carboxymaltose for heart failure with iron deficiency 

Dr. Robert Mentz from Duke University Medical Center, discusses the HEART-FID Trial, where they investigated the efficacy and safety of intravenous ferric carboxymaltose for HFrEF.
Learn more at cardiology-update.com
#heartfailure #HFrEF #irondeficiency #esccongress #cardiologist #cardiology #cardiologyupdate